Clinical Trial Spotlight
Participants are needed for an attention deficit hyperactivity disorder research study aimed at looking how omega-3 fatty acid supplements affect brain function in children with ADHD. This 10-week study includes a psychiatric interview and two MRI scans.
Right-handed male children, 8 to 12 years old, who are diagnosed with ADHD and have not received any psychostimulants in the past six months for one month or greater may be eligible for participation.
Participants may receive up to $160 for time and travel.
For more information, contact Deanna Dieckmann at 513-558-5059 or deanna.dieckmann@uc.edu.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.